Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach - Naqvi, Ahmad Abu Turab; Fatima, Kisa; Mohammad, Taj; Fatima, Urooj; Singh, Indrakant K.; Singh, Archana; Atif, Shaikh Muhammad; Hariprasad, Gururao; Hasan, Gulam Mustafa; Hassan, Md. Imtaiyaz (Biochimica et biophysica acta. Molecular basis of disease, 2020)
Keywords: Betacoronavirus - genetics; Betacoronavirus - isolation & purification; Betacoronavirus - pathogenicity; Comparative genomics; Coronavirus Infections - drug therapy; Coronavirus Infections - pathology; Coronavirus Infections - virology; COVID-19; Cytokines - metabolism; Drug target; Genetic Variation; Genome, Viral; Humans; Middle East Respiratory Syndrome Coronavirus - genetics; Middle East Respiratory Syndrome Coronavirus - isolation & purification; Middle East Respiratory Syndrome Coronavirus - pathogenicity; Molecular basis of pathogenesis; Molecular evolution; Pandemics; Pneumonia, Viral - drug therapy; Pneumonia, Viral - pathology; Pneumonia, Viral - virology; RNA-Dependent RNA Polymerase - genetics; SARS-CoV-2; Spike Glycoprotein, Coronavirus - chemistry; ORF; FDA; E; SARS-CoV; Molecular basis of pathogenesis; Comparative genomics; TMPRSS2; MERS-CoV; TNF; M; N; COVID-19; UTR; SARS-CoV-2; S; RBD; WHO; IFNγ; IL; Drug target; Nsp; G-CSF; ACE2; Molecular evolution; STAT; JAK